Relapsed Non Hodgkin Lymphoma Recruiting Phase 1 / 2 Trials for Dexamethasone (DB01234)

IndicationStatusPhase
DBCOND0062858 (Relapsed Non Hodgkin Lymphoma)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03892421Outpatient Administration of R-DHAP in Relapsed/Refractory Non-Hodgkin LymphomaTreatment